RegeneRx Biopharmaceuticals's total assets for Q were $186.81K, a decrease of -51.12% from the previous quarter. RGRX total liabilities were $3.93M for the fiscal quarter, a 2.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.